Literature DB >> 3064037

Management of otitis media in infants and children: current role of old and new antimicrobial agents.

C D Bluestone1.   

Abstract

Otitis media, the diagnosis most frequently made by the pediatrician, is most effectively treated with antimicrobial therapy. Amoxicillin (or ampicillin) has been the standard for infants and children with acute otitis media because it is safe and effective for most of the causative bacterial pathogens. Amoxicillin has also been shown to be effective for treatment of some children with otitis media with effusion ("secretory" otitis media) and is the recommended prophylactic antimicrobial agent for prevention of frequently recurrent acute otitis media. However, during the past decade there has been an increasing rate of bacteria that are resistant to amoxicillin, primarily beta-lactamase-producing Haemophilus influenzae and Branhamella catarrhalis. Because of the emergence of these bacteria, other antimicrobial agents both old and new have been advocated for treatment and prevention of otitis media; amoxicillin-clavulanate and cefuroxime axetil are the newer agents. These agents are indicated for selected infants and children but for most patients amoxicillin remains a safe and relatively inexpensive effective "old friend".

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3064037     DOI: 10.1097/00006454-198811001-00002

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  Epidemiology and pharmacoeconomic issues relating to acute respiratory tract infections and acute uncomplicated infections of the urinary tract.

Authors:  N M Graham
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

2.  Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children.

Authors:  Ravinder Kaur; Janet R Casey; Michael E Pichichero
Journal:  Vaccine       Date:  2010-12-01       Impact factor: 3.641

3.  Use of multiplex PCR for simultaneous detection of four bacterial species in middle ear effusions.

Authors:  P H Hendolin; A Markkanen; J Ylikoski; J J Wahlfors
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

4.  Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children.

Authors:  S E McLinn; M Moskal; J Goldfarb; F Bodor; G Aronovitz; R Schwartz; P Self; M J Ossi
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 5.  Antibiotic resistance in Haemophilus influenzae: mechanisms, clinical importance and consequences for therapy.

Authors:  R de Groot; G Dzoljic-Danilovic; B van Klingeren; W H Goessens; H J Neyens
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

6.  Release of leukotriene B4 from human neutrophils after interaction with nontypeable Haemophilus influenzae.

Authors:  R Garofalo; H Faden; S Sharma; P L Ogra
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 7.  Optimum management of the discharging ear.

Authors:  J Ruddy; R C Bickerton
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

8.  Cellular immunity to the P6 outer membrane protein of nontypeable Haemophilus influenzae.

Authors:  H Kodama; H Faden
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.